A detailed history of Atlas Capital Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 988 shares of DHR stock, worth $233,741. This represents 0.04% of its overall portfolio holdings.

Number of Shares
988
Previous 988 -0.0%
Holding current value
$233,741
Previous $247 Million 11.27%
% of portfolio
0.04%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$224.99 - $256.14 $6,524 - $7,428
-29 Reduced 2.85%
988 $237 Million
Q2 2022

Aug 16, 2022

BUY
$237.11 - $299.66 $65,205 - $82,406
275 Added 37.06%
1,017 $258 Million
Q4 2021

Feb 01, 2022

SELL
$292.08 - $329.01 $26,871 - $30,268
-92 Reduced 11.03%
742 $244 Million
Q3 2021

Oct 28, 2021

BUY
$272.21 - $332.43 $8,438 - $10,305
31 Added 3.86%
834 $253,000
Q2 2021

Jul 30, 2021

BUY
$225.08 - $271.69 $18,006 - $21,735
80 Added 11.07%
803 $215,000
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $52,700 - $60,874
-248 Reduced 25.54%
723 $160,000
Q3 2020

Oct 23, 2020

BUY
$177.16 - $215.33 $5,137 - $6,244
29 Added 3.08%
971 $209,000
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $7,850 - $10,786
-61 Reduced 6.08%
942 $166,000
Q4 2019

Jan 28, 2020

BUY
$133.47 - $153.48 $5,071 - $5,832
38 Added 3.94%
1,003 $153,000
Q1 2019

Apr 29, 2019

SELL
$97.62 - $132.29 $5,661 - $7,672
-58 Reduced 5.67%
965 $0
Q4 2018

Jan 29, 2019

BUY
$94.85 - $109.54 $5,501 - $6,353
58 Added 6.01%
1,023 $105,000
Q3 2018

Nov 09, 2018

SELL
$98.13 - $108.9 $189,096 - $209,850
-1,927 Reduced 66.63%
965 $0
Q2 2018

Jul 30, 2018

BUY
$96.1 - $103.24 $185,184 - $198,943
1,927 Added 199.69%
2,892 $0
Q1 2018

Apr 18, 2018

BUY
$92.16 - $103.8 $88,934 - $100,167
965 New
965 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.